Bryce Point Capital’s Hims & Hers Health HIMS Stock Holding History

Bryce Point Capital’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-37,272	Closed	-$901K	–	302
2024 Q4	$901K	Buy	+37,272	New	+$923K	0.26%	143

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Bryce Point Capital's HIMS Position: Q1 2025 in Review

Bryce Point Capital sold out of Hims & Hers Health (HIMS) in Q1 2025, closing a stake of 37,272 shares — an estimated $901K sold.

Bryce Point Capital first reported a position in HIMS in Q4 2024 and held it in 1 quarter. The position peaked at $901K in Q4 2024. 429 funds tracked by Wall St. Rank hold HIMS as of Q1 2025.

Bryce Point Capital reported no remaining Hims & Hers Health position as of Q1 2025 after selling out during the quarter.
Bryce Point Capital sold 37,272 Hims & Hers Health shares in Q1 2025, an estimated $901K.
Bryce Point Capital first reported a position in Hims & Hers Health in Q4 2024 and held it in 1 quarter.
Bryce Point Capital's Hims & Hers Health position peaked at $901K in Q4 2024.
429 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2025.

Based on Bryce Point Capital's 13F filing for Q1 2025, filed 7 May 2025.